Tao Yu

4.1k total citations · 2 hit papers
114 papers, 3.0k citations indexed

About

Tao Yu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Tao Yu has authored 114 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 24 papers in Oncology and 18 papers in Cancer Research. Recurrent topics in Tao Yu's work include Bone Metabolism and Diseases (13 papers), MicroRNA in disease regulation (8 papers) and RNA Interference and Gene Delivery (6 papers). Tao Yu is often cited by papers focused on Bone Metabolism and Diseases (13 papers), MicroRNA in disease regulation (8 papers) and RNA Interference and Gene Delivery (6 papers). Tao Yu collaborates with scholars based in China, United States and Switzerland. Tao Yu's co-authors include Yuan Xiong, Matthew J. Ellis, Ze Lin, Bobin Mi, Yiqiang Hu, Lang Chen, Guohui Liu, Jane Y. Wu, Takashi Nagasawa and Yan Zhu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Journal of Biological Chemistry.

In The Last Decade

Tao Yu

107 papers receiving 3.0k citations

Hit Papers

A Whole‐Course‐Repair System Based on Neurogenesis‐Angiog... 2022 2026 2023 2024 2023 2022 50 100 150 200 250

Peers

Tao Yu
Lei Guo China
Yiping Li China
Tan Zhang China
Xiaoli Ma China
Michael K. Dame United States
Bin Yu China
Lei Guo China
Tao Yu
Citations per year, relative to Tao Yu Tao Yu (= 1×) peers Lei Guo

Countries citing papers authored by Tao Yu

Since Specialization
Citations

This map shows the geographic impact of Tao Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Yu more than expected).

Fields of papers citing papers by Tao Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Yu. The network helps show where Tao Yu may publish in the future.

Co-authorship network of co-authors of Tao Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Yu. A scholar is included among the top collaborators of Tao Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Yu. Tao Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Baojie, Yongzheng Lu, Zhen Shang, et al.. (2025). Preclinical studies of the falnidamol as a highly potent and specific active ABCB1 transporter inhibitor. BMC Cancer. 25(1). 24–24.
2.
Li, Kai, Hui Fang, Dan Shao, et al.. (2025). ROS-neutralizing surface engineering protects immunotoxicity of organic nanoscintillator-directed radiodynamic therapy. Chinese Chemical Letters. 36(12). 111261–111261.
3.
Abulikemu, Alimire, Xuewei Zhang, Tao Meng, et al.. (2024). Particulate matter, polycyclic aromatic hydrocarbons and metals, platelet parameters and blood pressure alteration: Multi-pollutants study among population. The Science of The Total Environment. 941. 173657–173657. 3 indexed citations
4.
Abeysinghe, Sudeepa, et al.. (2024). ‘Small benefits and a certain risk’: Media representations of novel treatments for Alzheimer's disease. Social Science & Medicine. 365. 117554–117554. 1 indexed citations
5.
Yu, Tao, et al.. (2024). Spatial and temporal patterns of disease burden attributable to high BMI in Belt and Road Initiative countries, 1990–2019. Public Health Nutrition. 27(1). e158–e158. 2 indexed citations
6.
Xiao, Shan, Li Deng, Dan Qiao, et al.. (2023). Relationship between NUDT21 mediated alternative polyadenylation process and tumor. Frontiers in Oncology. 13. 1052012–1052012. 7 indexed citations
7.
Yu, Tao, et al.. (2023). Cell division cycle 42 effector protein 4 inhibits prostate cancer progression by suppressing ERK signaling pathway. SHILAP Revista de lepidopterología. 24(4). 840–847. 2 indexed citations
8.
Xiong, Yuan, Ze Lin, Pengzhen Bu, et al.. (2023). A Whole‐Course‐Repair System Based on Neurogenesis‐Angiogenesis Crosstalk and Macrophage Reprogramming Promotes Diabetic Wound Healing. Advanced Materials. 35(19). e2212300–e2212300. 263 indexed citations breakdown →
9.
Wang, Xiao, Shen Liu, Tao Yu, et al.. (2022). Inhibition of Integrin αvβ6 Activation of TGF‐β Attenuates Tendinopathy. Advanced Science. 9(11). e2104469–e2104469. 12 indexed citations
10.
Yu, Tao, Wei Zhu, Xiao Wang, et al.. (2021). Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification. Bone Research. 9(1). 19–19. 40 indexed citations
12.
Qiao, Liang, Tao Yu, Duanyu Ni, et al.. (2019). Application of robot-assisted stereoencephalography electrode implantation in epilepsy surgery. Zhonghua shenjing waike zazhi. 35(10). 1049–1053. 1 indexed citations
13.
Liu, Qing, et al.. (2018). Effect of Brain-Derived Neurotrophic Factor on the Neurogenesis and Osteogenesis in Bone Engineering. Tissue Engineering Part A. 24(15-16). 1283–1292. 60 indexed citations
14.
Qi, Xiaozhe, Tao Yu, Liye Zhu, et al.. (2014). Ochratoxin A induces rat renal carcinogenicity with limited induction of oxidative stress responses. Toxicology and Applied Pharmacology. 280(3). 543–549. 35 indexed citations
15.
16.
Yu, Tao. (2011). Professional literature annotation method based on domain ontology. Journal of Computer Applications. 1 indexed citations
17.
Crowder, Robert J., Chanpheng Phommaly, Tao Yu, et al.. (2009). PIK3CA and PIK3CB Inhibition Produce Synthetic Lethality when Combined with Estrogen Deprivation in Estrogen Receptor–Positive Breast Cancer. Cancer Research. 69(9). 3955–3962. 174 indexed citations
18.
Ellis, Matthew J., Lin Li, Robert J. Crowder, et al.. (2009). Phosphatidyl-inositol-3-kinase alpha catalytic subunit mutation and response to neoadjuvant endocrine therapy for estrogen receptor positive breast cancer. Breast Cancer Research and Treatment. 119(2). 379–390. 110 indexed citations
19.
Wen, Tieqiao, Wei Lü, Fuxue Chen, et al.. (2006). Apium graveolens L. accelerating differentiation of neural stem cells in vitro. Journal of Shanghai University (English Edition). 10(1). 89–94. 8 indexed citations
20.
Ellis, Matthew J., Andrew Coop, Baljit Singh, et al.. (2003). Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.. PubMed. 63(19). 6523–31. 167 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026